ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App
Shots: Generic of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg) will be launched at a list price of $24,000 for common course of therapy and will be available from Jan, 2019 The authorized generics will offer saving in Medicare Part D setting for up to $2,500 in out-of-pocket costs per course of therapy […]Read More
